Corbus Pharmaceuticals Holdings Inc expected to post a loss of $4.09 a share - Earnings Preview

Corbus Pharmaceuticals Holdings

05/05/2023 17:28

* Corbus Pharmaceuticals Holdings Inc  CRBP.OQ   CRBP.O  is
expected to show no change in quarterly revenue when it reports 
results on May 8 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Corbus
Pharmaceuticals
Holdings Inc is for a loss of $4.09 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 7.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Corbus
Pharmaceuticals Holdings Inc is $120​, above​ its last closing
price of $8.72. ​​​

This summary was machine generated May 5 at 16:28 GMT.  All
figures in US dollars  unless otherwise stated